{"version":"1.2.0","chapters":[{"startTime":0,"endTime":34.115},{"startTime":34.115,"endTime":129.851,"title":"Introduction to GLP-1 and Pancreatitis"},{"startTime":129.851,"endTime":297.612,"title":"Disordered Eating and GLP-1 Use"},{"startTime":297.612,"endTime":499.93,"title":"GLP-1 and Retinopathy Concerns"},{"startTime":499.93,"endTime":633.103,"title":"Managing Lipase Levels with GLP-1"},{"startTime":633.103,"endTime":699.616,"title":"GLP-1 Use in Pregnancy"},{"startTime":699.616,"endTime":715.39,"title":"Questions on Non-Incretin Therapies"},{"startTime":715.39,"endTime":826.2,"title":"CGM Interpretation and Finnernone"},{"startTime":826.2,"endTime":1069.289,"title":"SGLT2 Use in Primary Prevention"},{"startTime":1069.289,"endTime":1207.407,"title":"Perioperative Management of GLP-1"}]}